Hearing preservation in guinea pigs with long-standing endolymphatic hydrops

Otology and Neurotology

Volumn 32, Issue 9, 2011, Pages 1583-1589

  Momin, Suhael R ^a   Melki, Sami J ^a   Obokhare, Joy O ^a   Fares, Souha A ^b   Semaan, Maroun T ^a   Megerian, Cliff A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; NEUROPROTECTIVE AGENT; RILUZOLE;

ANIMAL; ARTICLE; COCHLEA; DRUG EFFECT; EVOKED BRAIN STEM AUDITORY RESPONSE; GUINEA PIG; HEARING; MENIERE DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; COCHLEA; DIMETHYL SULFOXIDE; ENDOLYMPHATIC HYDROPS; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GUINEA PIGS; HEARING; NEUROPROTECTIVE AGENTS; RILUZOLE;

EID: 81855161779     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3182382a64     Document Type: Article

References (34)

1. Hallpike C. Observations on the pathology of Meniere's syndrome. Proc R Soc Med 1938;31:55-73.
2. Yamakawa K. Uber die pathologische veranderung bie einem Meniere-Dranken. J Otorhinol Soc Japan 1938;44:2310-3.
3. Kimura R, Schuknecht H. Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac. Pract Otolaryngol 1965;27:343-54.
4. Kimura R. Experimental blockage of the endolymphatic duct and sac and its effect on the inner ear of the guinea pig. Ann Otol Rhinol Laryngol 1967;76:664-87.
5. Bixenstine PJ, Maniglia MP, Vasanji A, et al. Spiral ganglion degeneration patterns in endolymphatic hydrops. Laryngoscope 2008; 118:1217-23.
6. Hess A, Bloch W, Huverstuhl J, et al. Expression ofinducible nitric oxide synthase (iNOS/NOS II) in the cochlea of guinea pigs after intratympanical endotoxin-treatment. Brain Res 1999;830:113-22. (Pubitemid 29251718)
7. Megerian CA. Diameter of the cochlear nerve in endolymphatic hydrops: implications for the etiology of hearing loss in Meniere's disease. Laryngoscope 2005;115:1525-35. (Pubitemid 41330657)
8. Nadol JB Jr, Thornton AR. Ultrastructural findings in a case of Meniere's disease. Ann Otol Rhinol Laryngol 1987;96:449-54. (Pubitemid 18011980)
9. Momin SR, Melki SJ, Alagramam KN, et al. Spiral ganglion loss outpaces inner hair cell loss in endolymphatic hydrops. Laryngoscope 2010;120:159-65.
10. Nordang L, Cestreicher E, Arnold W, et al. Glutamate is the afferent neurotransmitter in the human cochlea. Acta Otolaryngol 2000; 120:359-62. (Pubitemid 34101857)
11. Khan MJ, Seidman MD, Quirk WS, et al. Effects of kynurenic acid as a glutamate receptor antagonist in the guinea pig. Eur Arch Otorhinolaryngol 2000;257:177-81. (Pubitemid 30259056)
12. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003;4:552-65. (Pubitemid 36773407)
13. Le Prell CG, Yagi M, Kawamoto K, et al. Chronic excitotoxicity in the guinea pig cochlea induces temporary functional deficits without disrupting otoacoustic emissions. J Acoust Soc Am 2004;116: 1044-56. (Pubitemid 39063194)
14. Kopke RD, Coleman JK, Liu J, et al. Candidate's thesis: enhancing intrinsic cochlear stress defenses to reduce noise-induced hearing loss. Laryngoscope 2002;112:1515-32. (Pubitemid 34977550)
15. Puel JL, Pujol R, Ladrech S, et al. Alpha-amino-3-hydroxy-5-methyl-4- isoxazole propionic acid electrophysiological and neuro-toxic effects in the guinea-pig cochlea. Neuroscience 1991;45: 63-72.
16. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424. (Pubitemid 46217686)
17. Labbe D, Teranishi MA, Hess A, et al. Activation of caspase-3 is associated with oxidative stress in the hydropic guinea pig cochlea. Hear Res 2005;202:21-7. (Pubitemid 40476093)
18. Calabrese V, Cornelius C, Maiolino L, et al. Oxidative stress, redox homeostasis and cellular stress response in Meniere's disease: role of vitagenes. Neurochem Res 2010;35:2208-17.
19. Wang J, Dib M, Lenoir M, et al. Riluzole rescues cochlear sensory cells from acoustic trauma in the guinea-pig. Neuroscience 2002; 111:635-48. (Pubitemid 34521901)
20. Melki SJ, Heddon CM, Frankel JK, et al. Pharmacological protection of hearing loss in the mouse model of endolymphatic hydrops. Laryngoscope 2010;120:1637-45.
21. Wu WJ, Sha SH, McLaren JD, et al. Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat. Hear Res 2001;158:165-78. (Pubitemid 32739289)
22. Andrews JC, Bohmer A. The surgical approach to the endo-lymphatic sac and the cochlear aqueduct in the guinea pig. Am J Otolaryngol 1989;10:61-6. (Pubitemid 19073051)
23. Megerian CA, Heddon C, Melki S, et al. Surgical induction of endolymphatic hydrops by obliteration of the endolymphatic duct. J Vis Exp 2010.
24. Zheng QY, Yu H, Washington JL III, et al. A new spontaneous mutation in the mouse protocadherin 15 gene. Hear Res 2006; 219:110-20. (Pubitemid 44189132)
25. Yagi M, Kanzaki S, Kawamoto K, et al. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J Assoc Res Otolaryngol 2000;1:315-25. (Pubitemid 32410196)
26. Leite MT, Gomes HC, Percario S, et al. Dimethyl sulfoxide as a block to the deleterious effect of nicotine in a random skin flap in the rat. Plast Reconstr Surg 2007;120:1819-22. (Pubitemid 350306676)
27. Lu C, Mattson MP. Dimethyl sulfoxide suppresses NMDA- and AMPA-induced ion currents and calcium influx and protects against excitotoxic death in hippocampal neurons. Exp Neurol 2001;170: 180-5. (Pubitemid 32641785)
28. Salim AS. Allopurinol and dimethyl sulfoxide improve treatment outcomes in smokers with peptic ulcer disease. J Lab Clin Med 1992;119:702-9.
29. Anne S, Kisley LB, Tajuddin ST, et al. Molecular changes associated with the endolymphatic hydrops model. Otol Neurotol 2007; 28:834-41. (Pubitemid 47329901)
30. Adams JC. Clinical implications of inflammatory cytokines in the cochlea: a technical note. Otol Neurotol 2002;23:316-22. (Pubitemid 34506640)
31. Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology ofMeniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005;26:74-81. (Pubitemid 40130213)
32. Shinomori YK, Kimura RS, Adams J. Changes in immunostaining for Na+, K+, 2Cl-cotransporter 1, taurine, and c-Jun N-terminal kinase in experimentally induced endolymphatic hydrops. ARO Abstract 2001;21:134.
33. Hockly E, Tse J, Barker AL, et al. Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease. Neurobiol Dis 2006;21:228-36. (Pubitemid 41817321)
34. Colovic M, Zennaro E, Caccia S. Liquid chromatographic assay for riluzole in mouse plasma and central nervous system tissues. JChromatogr B Analyt Technol Biomed Life Sci 2004;803:305-9. (Pubitemid 38452452)